Tyr Pharma's stock surged on positive data for pulmonary sarcoidosis treatment, but cash balance risk keeps investors ...
Hosted on MSN2d
Cantor Fitzgerald Initiates Coverage of aTyr Pharma (ATYR) with Overweight RecommendationFintel reports that on January 6, 2025, Cantor Fitzgerald initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a Overweight ...
Cantor Fitzgerald initiated coverage of aTyr Pharma (ATYR) with an Overweight rating. aTyr Pharma’s lead drug Efzofitimod is in two trials for ...
Equities research analysts at Cantor Fitzgerald started coverage on shares of Atyr PHARMA (NASDAQ:ATYR – Get Free Report) in a research report issued to clients and investors on Monday,Briefing.com ...
JonesTrading analyst Soumit Roy has maintained their bullish stance on JANX stock, giving a Buy rating on December 27.Stay Ahead of the ...
Top Wall Street analysts initiated coverage on these top names. For a complete view of all analyst rating changes, including ...
In this article, we are going to take a look at where Lantern Pharma Inc. (NASDAQ:LTRN) stands against the other AI stocks. Should original content contributors be paid every time large language ...
Moreover, the centre’s production-linked incentive (PLI) scheme for the pharma industry has benefited the sector significantly. Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance ...
The 80's and 90's spawned a host of selling models and most of us in the pharma business have been trained to use one or multiple different selling models. However, how many pharma executives ...
Like many in big business, the pharma industry had given more backing to Clinton, despite her anti-pharma policies - and now wait to see how the political upheaval will affect them. Hillary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback